Could a simple numbing injection during surgery stop Triple-Negative breast cancer from returning?
NCT ID NCT07458204
First seen Mar 20, 2026 · Last updated Apr 29, 2026 · Updated 6 times
Summary
This study tests whether injecting the numbing drug levobupivacaine around the tumor and nearby nerves during breast-conserving surgery can help prevent triple-negative breast cancer from coming back. About 760 women with triple-negative breast cancer who have already had chemotherapy will take part. The goal is to see if this simple, safe injection can improve recurrence-free survival at two years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institut Godinot
Reims, Champagne-Ardenne, 51100, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.